Clinical trial
Evaluation of the Bioavailability of Pramlintide
NCT00042471 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Bioavailability of Pramlintide
- Lead sponsor
- AstraZeneca
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2002
- Completion date
- December 31, 2002
- Enrollment
- 75 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.